Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

651 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Fixed Exchange Rate In Pricing Of Pharmaceuticals And Its Impact

    Turkey's pharmaceutical pricing system relies on a reference pricing model tied to EU member state prices, but uses a fixed annual exchange rate set at 60% of the previous year's average Euro value.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Guideline On Circumstances Requiring Reissue Of A Marketing Authorization For A Licensed Pharmaceutical

    The transfer of pharmaceutical marketing authorizations ("MA") entails intricate and interconnected procedures. Especially when it comes to imported pharmaceuticals...
    TurkeyFood, Drugs, Healthcare, Life Sciences
Gün + Partners
Gün + Partners
  • Article

    Guideline On Import Applications And Marketing Authorization Has Been Updated

    The Guideline on Import Applications and Marketing Authorization prepared by the Turkish Medicines and Medical Devices Agency and entered into force on 29 August 2022 has been updated.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Guideline On Procurement Of Medicines From Abroad Has Been Updated

    The Guideline on Procurement of Medicines from Abroad has been updated in line with the Regulation and published by the Agency on 20 April 2023.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Interactions With HCPs, Transfer Of Values And Payments

    The Regulation on the Promotional Activities of Pharmaceutical Products for Human Use ("Promotion Regulation"), dated July 3, 2015...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Interactions With Health Care Professionals, Transfer Of Values And Conditions Of Payment

    Promotion activities for pharmaceutical products for human use are regulated under the Regulation on the Promotion of Medicinal Products for Human Use dated 3 July 2015...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Named Patient Program In Turkey

    Named Patient Program ("NPP") is one of the exceptional pharmaceutical importation regimes for products that are not authorized or authorized...
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Notification Obligation In Case Of Supply Interruption Of Medical Devices

    The Turkish Medicines and Medical Devices Agency (the "Agency") has announced new notification obligations for economic operators in the event of an interruption or discontinuation (termination) of the supply of medical devices.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Recent Developments In The Healthcare Sector - August 2021

    The Turkish Pharmaceuticals and Medical Devices Authority has published announcements on the implementation of the Medical Device Regulation and the normalization process following the COVID-19 pandemic.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Esin Attorney Partnership
    Esin Attorney Partnership
  • Article

    Recent Regulatory Developments In Turkey's Pharmaceutical Sector

    June 2021 – In May 2021, the Turkish Medicine and Medical Devices Authority ("TITCK") made two regulatory updates in the pharmaceutical sector in response to feedback from sector participants.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gen Temizer Erdogan Girgin Attorney Partnership
    Gen Temizer Erdogan Girgin Attorney Partnership
  • Article

    Special Regulation Pertaining To Medical Device Clinical Researches In Turkey

    While debates related to clinical research and its legal foundations within Turkey continues, a special regulation has been issued pertaining to Medical Device clinical research.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    The Medicines And Medical Devices Agency Of Turkey Has Re-Evaluated Some Of The Health Declaration Statements In The Guideline On The Use Of Health Declaration In Food And Food Supplements

    In accordance with the Regulation on the Use of Health Declarations in Food and Food Supplements ("Regulation") and the Guideline on the Use of Health Declarations in Food and Food Supplements
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Turkey A Rising Star In Pharmerging Market

    The market size for Turkey stood at $6.2 billion in 2014 and is expected to grow to $10.9 bn until 2019.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Gün + Partners
    Gün + Partners
  • Article

    Turkey Announces Establishment Of Biotechnology Institute

    The Turkish Health Institutes Directorate ("Directorate") has announced establishment of the Biotechnology Institute ("Institute").
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Turkey Announces The Regulation On Pharmaceutical Establishments And Products In Pharmaceutical Establishments

    The Regulation on Pharmaceutical Establishments and Products in Pharmaceutical Establishments, drafted by the Turkish Pharmaceuticals and Medical Devices Agency, was published in Official Gazette dated 15 June 2022 and numbered 31867 and entered into force on the same date.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Turkish Pharmaceuticals And Medical Devices Agency Published The Q&A Session Of The Cosmetics And Biocidal Legislation Training

    Turkey Pharmaceuticals and Medical Devices Agency organized a Cosmetic and Biocidal Legislation Training on 25-27 November 2021 with the participation of companies in the sector.
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    US Food And Drug Administration Issues New Biosimilars Action Plan

    The US Food and Drug Administration issued a new Biosimilars Action Plan in July 2018 ("Plan").
    TurkeyFood, Drugs, Healthcare, Life Sciences
    Moroglu Arseven
    Moroglu Arseven
  • Article

    A Question Of Timing: Negative Declaratory Relief In Pharmaceutical IP Practice

    Istanbul's First Instance IP Court recently dismissed a negative declaratory action against our client citing plaintiff's lack of standing because the pharmaceutical at issue was unlicensed as of the when the action was started.
    TurkeyIntellectual Property
    Moroglu Arseven
    Moroglu Arseven
  • Article

    Combating Counterfeit Hygiene Products, Along With COVID-19

    Turkey's first official diagnosis of COVID-19, which is considered to have begun in China's Whuan city in December 2019 and which has spread to millions worldwide in the following months, was announced on 11 March 2020.
    TurkeyIntellectual Property
    Gün + Partners
    Gün + Partners
  • Article

    European Union Initiates Dispute Complaint Against Turkey's Measures On Imports Of Pharmaceutical Products

    There are certain measures adopted by Turkish authorities which ensure the operation of this localization process.
    TurkeyInternational Law
    ELIG Gürkaynak Attorneys-at-Law
    ELIG Gürkaynak Attorneys-at-Law
  • Showing 141–160 of 651 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics